It is known from preclinical research that PSMA expression in prostate cancer cells is inversely modulated by the AR-signaling cascade, eventually involving the FOLH1 gene, which encodes PSMA [21,22]. The gene discussed is FOLH1; the disease is prostate carcinoma.